B32 Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

Autor:	Deborah Ayeni, Alexis A. Guernet, Robert J. Homer, Darren Cross, Tyler F. Stewart, Maria Emanuela Cuomo, Arun M. Unni, Hina Khan, Kristin E Price, Kamrine E. Poels, William W. Lockwood, Kumar Dilip Ashtekar, Amy Nagelberg, Susan M. Kaech, Jacqueline H. Starrett, Franziska Michor, Mmaserame Gaefele, Alexandra Kuhlmann, I.K. van Alderwerelt van Rosenburgh, Sarah B. Goldberg, Katerina Politi, Paul D. Smith, Mark A. Lemmon, D. Farnsworth
Rok vydání:	2020
Předmět:	Pulmonary and Respiratory Medicine Drug business.industry media_common.quotation_subject First line Oncology Egfr mutation Cancer research Medicine Osimertinib Sensitivity (control systems) Allele business media_common
Zdroj:	Journal of Thoracic Oncology. 15:S36
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ae422cdebe13979fb5d73e28fbed68c9 https://doi.org/10.1016/j.jtho.2019.12.097 Zobrazit plný text záznamu